FindTrial
Sign In

Effect of optimized cardiac rehabilitation therapeutic regimen on chronic heart failure

Effect of optimized cardiac rehabilitation therapeutic regimen on chronic heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020100
Enrollment
Unknown
Registered
2018-12-14
Start date
2018-12-30
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

Control group:Routine medications for heart?failure
Comprehensive group :Comprehensive treatment
Optimized group :Optimized comprehensive treatment

Sponsors

the Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: Chronic heart failure patients with class I to III heart function according to NYHA classification.

Exclusion criteria

Exclusion criteria: Class IV heart function; renal failure and dialysis treatment; liver disease; unwillingness to provide informed consent.

Design outcomes

Primary

MeasureTime frame
B type natriuretic peptide;NT-proBNP;echocardiographic data;Pulmonary artery pressure;Chronic inflammation measurement;Endothelial function;Quality of daily life;parameter in ambulatory ECG;end point;—

Countries

China

Contacts

Public ContactJuan Wang

The Second hosptial of Shandong University

moonlikewang@163.com+86 17660080380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026